CONMED Corp — Director's Dealing 2021

Mar 4, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2021-03-01

Reporting Person: KENNEDY JOHN JED (Group Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-01	Common Stock	M	1250	—	Acquired	6859	Direct
2021-03-01	Common Stock	F	367	$122.55	Disposed	6492	Direct
2021-03-01	Common Stock	M	1250	—	Acquired	7742	Direct
2021-03-01	Common Stock	F	367	$122.55	Disposed	7375	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-01	Rsus (restricted Stock Units)	$0	M	1250	Disposed	2029-03-01	Common Stock (1250)	Direct
2021-03-01	Rsus (restricted Stock Units)	$0	M	1250	Disposed	2030-03-02	Common Stock (1250)	Direct
2021-03-01	Rsus (restricted Stock Units)	$0	A	4200	Acquired	2031-03-01	Common Stock (4200)	Direct
2021-03-01	Options To Purchase Common Stock	$122.55	A	8250	Acquired	2031-03-01	Common Stock (8250)	Direct

Footnotes

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.

F2: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period